Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis

PPAR Research

Volumn , Issue , 2009, Pages

  Penberthy, W Todd ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; DEXAMETHASONE; DRONABINOL; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; HEME OXYGENASE 1; HIGH DENSITY LIPOPROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; MANGANESE SUPEROXIDE DISMUTASE; MINOCYCLINE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOIC ACID; VITAMIN D;

ALLERGIC ENCEPHALOMYELITIS; ANGIOGENESIS; BLOOD BRAIN BARRIER; DEMENTIA; DEMYELINATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DYSLIPIDEMIA; GENE INDUCTION; GENE TARGETING; HUMAN; LIPODYSTROPHY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PELLAGRIC DEMENTIA; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; TRANSCRIPTOMICS;

EID: 66949157991     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2009/853707     Document Type: Review

References (122)

1. Bitsch A., Brck W., Differentiation of multiple sclerosis subtypes: implications for treatment CNS Drugs 2002 16 6 405 418 (Pubitemid 34638929)
2. Noseworthy J. H., Lucchinetti C., Rodriguez M., Weinshenker B. G., Multiple sclerosis The New England Journal of Medicine 2000 343 13 938 952
3. Tischner D., Reichardt H. M., Glucocorticoids in the control of neuroinflammation Molecular and Cellular Endocrinology 2007 275 1-2 62 70 (Pubitemid 47259277)
4. Grohmann U., Volpi C., Fallarino F., Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy Nature Medicine 2007 13 5 579 586 (Pubitemid 46828479)
5. Puccetti P., Grohmann U., IDO and regulatory T cells: a role for reverse signalling and non-canonical NF- B activation Nature Reviews Immunology 2007 7 10 817 823 (Pubitemid 47480306)
6. Xystrakis E., Kusumakar S., Boswell S., Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients The Journal of Clinical Investigation 2006 116 1 146 155 (Pubitemid 43121799)
7. Xiao B.-G., Liu X., Link H., Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis Steroids 2004 69 10 653 659 (Pubitemid 39297704)
8. Lee T.-S., Chau L.-Y., Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice Nature Medicine 2002 8 3 240 246 (Pubitemid 34250101)
9. Chora. A., Fontoura P., Cunha A., Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation The Journal of Clinical Investigation 2007 117 2 438 447 (Pubitemid 46203972)
10. Stern J. N. H., Keskin D. B., Zhang H., Lv H., Kato Z., Strominger J. L., Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice Proceedings of the National Academy of Sciences of the United States of America 2008 105 13 5172 5176
11. Pfefferkorn E. R., Interferon blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan Proceedings of the National Academy of Sciences of the United States of America 1984 81 3 908 912 (Pubitemid 14197611)
12. Byrne G. I., Lehmann L. K., Landry G. J., Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells Infection and Immunity 1986 53 2 347 351 (Pubitemid 16073864)
13. MacKenzie C. R., Hadding U., Dubener W., Interferon- -induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci Journal of Infectious Diseases 1998 178 3 875 878 (Pubitemid 28397242)
14. Sanni L. A., Thomas S. R., Tattam B. N., Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria American Journal of Pathology 1998 152 2 611 619 (Pubitemid 28106408)
15. Bodaghi B., Goureau O., Zipeto D., Laurent L., Virelizier J.-L., Michelson S., Role of IFN- -induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells The Journal of Immunology 1999 162 2 957 964 (Pubitemid 29035421)
16. Silva N. M., Rodrigues C. V., Santoro M. M., Reis L. F. L., Alvarez-Leite J. I., Gazzinelli R. T., Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1 Infection and Immunity 2002 70 2 859 868 (Pubitemid 34083850)
17. Adams O., Besken K., Oberdrfer C., MacKenzie C. R., Ring D., Dubener W., Inhibition of human herpes simplex virus type 2 by interferon and tumor necrosis factor is mediated by indoleamine 2,3-dioxygenase Microbes and Infection 2004 6 9 806 812 (Pubitemid 39055542)
18. Adams O., Besken K., Oberdrfer C., MacKenzie C. R., Takikawa O., Dubener W., Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections Journal of Virology 2004 78 5 2632 2636 (Pubitemid 38228963)
19. Wallack E. M., Callon R., Liver injury associated with the -interferons for MS Neurology 2004 63 6 1142 1143
20. Stve O., Bennett J. L., Hemmer B., Pharmacological treatment of early multiple sclerosis Drugs 2008 68 1 73 83 (Pubitemid 350275685)
21. Baxter A. G., The origin and application of experimental autoimmune encephalomyelitis Nature Reviews Immunology 2007 7 11 904 912 (Pubitemid 350006239)
22. Steinman L., Zamvil S. S., How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis Annals of Neurology 2006 60 1 12 21
23. Diab A., Deng C., Smith J. D., Peroxisome proliferator-activated receptor- agonist 15-deoxy- 12, 14 -prostaglandin J 2 ameliorates experimental autoimmune encephalomyelitis The Journal of Immunology 2002 168 5 2508 2515 (Pubitemid 34171857)
24. Diab A., Hussain R. Z., Lovett-Racke A. E., Chavis J. A., Drew P. D., Racke M. K., Ligands for the peroxisome proliferator-activated receptor- and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis Journal of Neuroimmunology 2004 148 1-2 116 126 (Pubitemid 38229564)
25. Kliewer S. A., Lenhard J. M., Willson T. M., Patel I., Morris D. C., Lehmann J. M., A prostaglandin J 2 metabolite binds peroxisome proliferator-activated receptor and promotes adipocyte differentiation Cell 1995 83 5 813 819 (Pubitemid 3006325)
26. Raikwar H. P., Muthian G., Rajasingh J., Johnson C. N., Bright J. J., PPAR antagonists reverse the inhibition of neural antigen-specific Th 1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy- 12, 14 -prostaglandin J 2 Journal of Neuroimmunology 2006 178 1-2 76 86 (Pubitemid 44307334)
27. Semple R. K., Chatterjee V. K. K., ORahilly S., PPAR and human metabolic disease The Journal of Clinical Investigation 2006 116 3 581 589 (Pubitemid 43326862)
28. Knowles H. J., te Poole R., Workman P., Harris A. L., Niacin induces PPAR expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways Biochemical Pharmacology 2006 71 5 646 656 (Pubitemid 43121998)
29. Rubic T., Trottmann M., Lorenz R. L., Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin Biochemical Pharmacology 2004 67 3 411 419 (Pubitemid 38236129)
30. Carlson L. A., Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review Journal of Internal Medicine 2005 258 2 94 114 (Pubitemid 41025967)
31. Kaneko S., Wang J., Kaneko M., Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models The Journal of Neuroscience 2006 26 38 9794 9804 (Pubitemid 44427718)
32. Henderson L. M., Gross C. J., Metabolism of niacin and niacinamide in perfused rat intestine Journal of Nutrition 1979 109 4 654 662 (Pubitemid 9158382)
33. Micheli V., Simmonds H. A., Sestini S., Ricci C., Importance of nicotinamide as an NAD precursor in the human erythrocyte Archives of Biochemistry and Biophysics 1990 283 1 40 45 (Pubitemid 20380643)
34. Grant R. S., Kapoor V., Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates Journal of Neurochemistry 1998 70 4 1759 1763 (Pubitemid 28136993)
35. Sasaki Y., Araki T., Milbrandt J., Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy The Journal of Neuroscience 2006 26 33 8484 8491 (Pubitemid 44316176)
36. Adalbert R., Gillingwater T. H., Haley J. E., A rat model of slow Wallerian degeneration (W l d S) with improved preservation of neuromuscular synapses European Journal of Neuroscience 2005 21 1 271 277 (Pubitemid 40193896)
37. Araki T., Sasaki Y., Milbrandt J., Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration Science 2004 305 5686 1010 1013 (Pubitemid 39071777)
38. Bishop N. A., Guarente L., Genetic links between diet and lifespan: shared mechanisms from yeast to humans Nature Reviews Genetics 2007 8 11 835 844 (Pubitemid 47609089)
39. Li X., Zhang S., Blander G., Tse J. G., Krieger M., Guarente L., SIRT1 deacetylates and positively regulates the nuclear receptor LXR Molecular Cell 2007 28 1 91 106 (Pubitemid 47531974)
40. Beirowski B., Babetto E., Gilley J., Non-nuclear W l d S determines its neuroprotective efficacy for axons and synapses in vivo The Journal of Neuroscience 2009 29 3 653 668
41. Brown G. C., Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase Biochemical Society Transactions 2007 35 5 1119 1121 (Pubitemid 350206442)
42. Penberthy W. T., Tsunoda I., The importance of NAD in multiple sclerosis Current Pharmaceutical Design 2009 15 1 64 99
43. McCarty M. F., Russell A. L., Niacinamide therapy for osteoarthritisdoes it inhibit nitric oxide synthase induction by interleukin-1 in chondrocytes? Medical Hypotheses 1999 53 4 350 360 (Pubitemid 29531377)
44. Powers D. A., Hereford L., Cole T., Electroporation: a method for transferring genes into the gametes of zebrafish (Brachydanio rerio), channel catfish (Ictalurus punctatus), and common carp (Cyprinus carpio) Molecular Marine Biology and Biotechnology 1992 1 4-5 301 308
45. Eklund B., Kaijser L., Nowak J., Wennmalm A., Prostaglandins contribute to the vasodilation induced by nicotinic acid Prostaglandins 1979 17 6 821 830 (Pubitemid 10221950)
46. Morrow J. D., Parsons W. G. III, Roberts L. J. II, Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid Prostaglandins 1989 38 2 263 274 (Pubitemid 19206949)
47. Olsson A. G., Carlson L. A., Anggard E., Ciabattoni G., Prostacyclin production augmented in the short term by nicotinic acid The Lancet 1983 2 8349 565 566
48. Beny Z., Gille A., Bennett C. L., Clausen B. E., Offermanns S., Nicotinic acid-induced flushing is mediated by activation of epidermal Langerhans cells Molecular Pharmacology 2006 70 6 1844 1849 (Pubitemid 44771899)
49. Braun D., Longman R. S., Albert M. L., A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation Blood 2005 106 7 2375 2381 (Pubitemid 41510810)
50. von Bergwelt-Baildon M. S., Popov A., Saric T., CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition Blood 2006 108 1 228 237 (Pubitemid 43990633)
51. Guillemin G. J., Smythe G., Takikawa O., Brew B. J., Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons GLIA 2005 49 1 15 23 (Pubitemid 40023649)
52. Kwidzinski E., Bunse J., Aktas O., Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation The FASEB Journal 2005 19 10 1347 1349 (Pubitemid 41113745)
53. Kwidzinski E., Bunse J., Kovac A. D., IDO (indolamine 2,3-dioxygenase) expression and function in the CNS Advances in Experimental Medicine and Biology 2003 527 113 118 (Pubitemid 38197635)
54. Sakurai K., Zou J.-P., Tschetter J. R., Ward J. M., Shearer G. M., Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis Journal of Neuroimmunology 2002 129 1-2 186 196 (Pubitemid 34874924)
55. Offermanns S., The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target Trends in Pharmacological Sciences 2006 27 7 384 390 (Pubitemid 43963187)
56. Kamanna V. S., Kashyap M. L., Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents? The American Journal of Cardiology 2007 100 11, supplement 1 S53 S61
57. Fujiwara M., Egashira N., New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application Journal of Pharmacological Sciences 2004 96 4 362 366 (Pubitemid 40144052)
58. Lyman W. D., Sonett J. R., Brosnan C. F., Elkin R., Bornstein M. B., 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis Journal of Neuroimmunology 1989 23 1 73 81 (Pubitemid 19125801)
59. Pryce G., Ahmed Z., Hankey D. J. R., Cannabinoids inhibit neurodegeneration in models of multiple sclerosis Brain 2003 126 10 2191 2202 (Pubitemid 37432364)
60. Luthra Y. K., Esber H. J., Lariviere D. M., Rosenkrantz H., Assessment of tolerance to immunosuppressive activity of 9-tetrahydrocannabinol in rats Journal of Immunopharmacology 1980 2 2 245 256 (Pubitemid 11190080)
61. Nurmikko T. J., Serpell M. G., Hoggart B., Toomey P. J., Morlion B. J., Haines D., Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial Pain 2007 133 13 210 220 (Pubitemid 350141682)
62. Smith P. F., Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances Expert Review of Neurotherapeutics 2007 7 9 1157 1163 (Pubitemid 47451022)
63. Mestre L., Correa F., Arvalo-Martn A., Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis Journal of Neurochemistry 2005 92 6 1327 1339 (Pubitemid 40389203)
64. Ortega-Gutirrez S., Molina-Holgado E., revalo-Martn., Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis The FASEB Journal 2005 19 10 1338 1340 (Pubitemid 41113742)
65. DAgostino G., La Rana G., Russo R., Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor- agonist, modulates carrageenan-induced paw edema in mice Journal of Pharmacology and Experimental Therapeutics 2007 322 3 1137 1143 (Pubitemid 47295805)
66. OSullivan S. E., Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors British Journal of Pharmacology 2007 152 5 576 582
67. Rockwell C. E., Kaminski N. E., A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes Journal of Pharmacology and Experimental Therapeutics 2004 311 2 683 690 (Pubitemid 39391556)
68. Rockwell C. E., Snider N. T., Thompson J. T., Vanden Heuvel J. P., Kaminski N. E., Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor independently of cannabinoid receptors 1 and 2 Molecular Pharmacology 2006 70 1 101 111 (Pubitemid 43920800)
69. Hafler D. A., Compston A., Sawcer S., Risk alleles for multiple sclerosis identified by a genomewide study The New England Journal of Medicine 2007 357 9 851 862 (Pubitemid 47347319)
70. Drechsler Y., Dolganiuc A., Norkina O., Heme oxygena-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes The Journal of Immunology 2006 177 4 2592 2600 (Pubitemid 44201018)
71. Ricchetti G. A., Williams L. M., Foxwell B. M. J., Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide Journal of Leukocyte Biology 2004 76 3 719 726 (Pubitemid 39129106)
72. Zhou P., LItalien L., Hodges D., Schebye X. M., Pivotal roles of CD 4 + effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors The Journal of Immunology 2007 179 11 7365 7375
73. Barrat F. J., Cua D. J., Boonstra A., In vitro generation of interleukin 10-producing regulatory CD 4 + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines The Journal of Experimental Medicine 2002 195 5 603 616 (Pubitemid 34461505)
74. Cantorna M. T., Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease Progress in Biophysics and Molecular Biology 2006 92 1 60 64 (Pubitemid 43831951)
75. Cantorna M. T., Hayes C. E., DeLuca H. F., 1,25-dihydroxyvitamin D 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis Proceedings of the National Academy of Sciences of the United States of America 1996 93 15 7861 7864 (Pubitemid 26277129)
76. van der Mei I. A. F., Ponsonby A.-L., Blizzard L., Dwyer T., Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation Neuroepidemiology 2001 20 3 168 174 (Pubitemid 32718873)
77. Brown S. J., The role of vitamin D in multiple sclerosis Annals of Pharmacotherapy 2006 40 6 1158 1161 (Pubitemid 43886975)
78. Mabley J. G., Wallace R., Pacher P., Murphy K., Szab C., Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D International Journal of Molecular Medicine 2007 19 6 947 952
79. Alano C. C., Kauppinen T. M., Valls A. V., Swanson R. A., Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations Proceedings of the National Academy of Sciences of the United States of America 2006 103 25 9685 9690 (Pubitemid 43955885)
80. Kauppinen T. M., Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease Neurochemistry International 2007 50 7-8 954 958 (Pubitemid 46962810)
81. Luccarini I., Ballerini C., Biagioli T., Combined treatment with atorvastatin and minocycline suppresses severity of EAE Experimental Neurology 2008 211 1 214 226
82. Ruggieri M., Pica C., Lia A., Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients Journal of Neuroimmunology 2008 197 2 140 146
83. Zabad R. K., Metz L. M., Todoruk T. R., The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study Multiple Sclerosis 2007 13 4 517 526 (Pubitemid 46796512)
84. Mellor A. L., Munn D. H., IDO expression by dendritic cells: tolerance and tryptophan catabolism Nature Reviews Immunology 2004 4 10 762 774 (Pubitemid 39336293)
85. Penberthy W. T., Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease Current Drug Metabolism 2007 8 3 245 266 (Pubitemid 46621674)
86. Qi X., Lewin A. S., Sun L., Hauswirth W. W., Guy J., Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis Investigative Ophthalmology and Visual Science 2007 48 2 681 691 (Pubitemid 351260701)
87. Alexander A. M., Crawford M., Bertera S., Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes Diabetes 2002 51 2 356 365 (Pubitemid 34764790)
88. Jasperson L. K., Bucher C., Panoskaltsis-Mortari A., Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality Blood 2008 111 6 3257 3265
89. Liu Y., Zhu B., Luo L., Li P., Paty D. W., Cynader M. S., Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis NeuroReport 2001 12 9 1841 1845 (Pubitemid 32553694)
90. Owuor E. D., Kong A.-N. T., Antioxidants and oxidants regulated signal transduction pathways Biochemical Pharmacology 2002 64 5-6 765 770 (Pubitemid 35238028)
91. Syburra C., Passi S., Oxidative stress in patients with multiple sclerosis Ukrainskii Biokhimicheskii Zhurnal 1999 71 3 112 115
92. Gros-Louis F., Gaspar C., Rouleau G. A., Genetics of familial and sporadic amyotrophic lateral sclerosis Biochimica et Biophysica Acta 2006 1762 11-12 956 972 (Pubitemid 44781174)
93. Andreassen O. A., Ferrante R. J., Klivenyi P., Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis Annals of Neurology 2000 47 4 447 455 (Pubitemid 30194600)
94. Zimmerman M. C., Oberley L. W., Flanagan S. W., Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels Journal of Neurochemistry 2007 102 3 609 618 (Pubitemid 47057273)
95. Li Y., Huang T.-T., Carlson E. J., Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase Nature Genetics 1995 11 4 376 381
96. Elchuri S., Oberley T. D., Qi W., CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life Oncogene 2005 24 3 367 380 (Pubitemid 40188585)
97. Curtis C., Landis G. N., Folk D., Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes Genome Biology 2007 8 12, article R262 1 27
98. Maresz K., Pryce G., Ponomarev E. D., Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB 1 on neurons and CB 2 on autoreactive T cells Nature Medicine 2007 13 4 492 497 (Pubitemid 46559830)
99. Carvalho J. F., Blank M., Shoenfeld Y., Vascular endothelial growth factor (VEGF) in autoimmune diseases Journal of Clinical Immunology 2007 27 3 246 256 (Pubitemid 46790822)
100. Tang Y., Zhou L., Gunnet J. W., Wines P. G., Cryan E. V., Demarest K. T., Enhancement of arachidonic acid signaling pathway by nicotinic acid receptor HM74A Biochemical and Biophysical Research Communications 2006 345 1 29 37
101. Bao B.-Y., Yao J., Lee Y.-F., 1, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis Carcinogenesis 2006 27 9 1883 1893 (Pubitemid 44288669)
102. Chintalgattu V., Harris G. S., Akula S. M., Katwa L. C., PPAR- agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts Cardiovascular Research 2007 74 1 140 150 (Pubitemid 46366953)
103. Xin X., Yang S., Kowalski J., Gerritsen M. E., Peroxisome proliferator-activated receptor ligands are potent inhibitors of angiogenesis in vitro and in vivo Journal of Biological Chemistry 1999 274 13 9116 9121 (Pubitemid 29164719)
104. Massacesi L., Abbamondi A. L., Giorgi C., Sarlo F., Lolli F., Amaducci L., Suppression of experimental allergic encephalomyelitis by retinoic acid Journal of the Neurological Sciences 1987 80 1 55 64 (Pubitemid 17094624)
105. Massacesi L., Abbamondi A. L., Sarlo F., Amaducci L., The control of experimental allergic encephalomyelitis with retinoic acid. Further studies Rivista di Neurologia 1987 57 3 166 169 (Pubitemid 17129683)
106. Racke M. K., Burnett D., Pak S.-H., Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course Journal of Immunology 1995 154 1 450 458
107. Xu J., Storer P. D., Chavis J. A., Racke M. K., Drew P. D., Agonists for the peroxisome proliferator-activated receptor- and the retinoid X receptor inhibit inflammatory responses of microglia Journal of Neuroscience Research 2005 81 3 403 411 (Pubitemid 41359295)
108. Arsenou E. S., Papadimitriou E. P., Kliafa E., Hountala M., Nikolaropoulos S. S., Effects of retinoic acid steroidal analogs on human leukemic HL60 cell proliferation in vitro and on angiogenesis in vivo Anti-Cancer Drugs 2005 16 2 151 158 (Pubitemid 40250610)
109. Hoffmann S., Rockenstein A., Ramaswamy A., Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells Molecular and Cellular Endocrinology 2007 264 1-2 74 81 (Pubitemid 46097303)
110. Tee M. K., Vigne J.-L., Taylor R. N., All-trans retinoic acid inhibits vascular endothelial growth factor expression in a cell model of neutrophil activation Endocrinology 2006 147 3 1264 1270 (Pubitemid 43244359)
111. Pisanti S., Borselli C., Oliviero O., Laezza C., Gazzerro P., Bifulco M., Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy Journal of Cellular Physiology 2007 211 2 495 503 (Pubitemid 46580103)
112. Potente M., Ghaeni L., Baldessari D., SIRT1 controls endothelial angiogenic functions during vascular growth Genes and Development 2007 21 20 2644 2658 (Pubitemid 47607673)
113. Drew P. D., Storer P. D., Xu J., Chavis J. A., Hormone regulation of microglial cell activation: relevance to multiple sclerosis Brain Research Reviews 2005 48 2 322 327 (Pubitemid 40585762)
114. Benson S., Padmanabhan S., Kurtz T. W., Pershadsingh H. A., Ligands for the peroxisome proliferator-activated receptor- and the retinoid X receptor- exert synergistic antiproliferative effects on human coronary artery smooth muscle cells Molecular Cell Biology Research Communications 2000 3 3 159 164 (Pubitemid 30430016)
115. Ray D. M., Bernstein S. H., Phipps R. P., Human multiple myeloma cells express peroxisome proliferator-activated receptor and undergo apoptosis upon exposure to PPAR ligands Clinical Immunology 2004 113 2 203 213 (Pubitemid 39296854)
116. Worley J. R., Baugh M. D., Hughes D. A., Metalloproteinase expression in PMA-stimulated THP-1 cells: effects of peroxisome proliferator-activated receptor- (PPAR ) agonists and 9- cis -retinoic acid Journal of Biological Chemistry 2003 278 51 51340 51346 (Pubitemid 38020373)
117. Arvalo-Martn A., Garca-Ovejero D., Rubio-Araiz A., Gmez O., Molina-Holgado F., Molina-Holgado E., Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2 European Journal of Neuroscience 2007 26 6 1548 1559 (Pubitemid 47416530)
118. Hankes L. V., Coenen H. H., Rota E., Effect of Huntingtons and Alzheimers diseases on the transport of nicotinic acid or nicotinamide across the human blood-brain barrier Advances in Experimental Medicine and Biology 1991 294 675 678
119. Hoffer A., Treatment of arthritis by nicotinic acid and nicotinamide Canadian Medical Association Journal 1959 81 4 235 238
120. Hoffer A., Adventures in Psychiatry: The Scientific Memoirs of Dr. Abram Hoffer 2005 Alton, Ont, USA KOS Publishing
121. Osmond H., Hoffer A., Massive niacin treatment in schizophrenia. Review of a nine-year study The Lancet 1962 279 7224 316 320
122. Chen J., Zhou Y., Mueller-Steiner S., SIRT1 protects against microglia-dependent amyloid- toxicity through inhibiting NF- B signaling The Journal of Biological Chemistry 2005 280 48 40364 40374 (Pubitemid 41779174)